Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer

A 75-year-old man with stage IV lung adenocarcinoma was treated with osimertinib due to disease progression despite having been administered erlotinib. Both an epidermal growth factor receptor (EGFR) L858R mutation on exon 21 and a T790M mutation on exon 20 were detected in a specimen from a recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Yoshiya, Kawaguchi, Tomoya, Yamamoto, Norio, Sawa, Kenji, Yoshimoto, Naoki, Suzumura, Tomohiro, Watanabe, Tetsuya, Mitsuoka, Shigeki, Asai, Kazuhisa, Kimura, Tatsuo, Yoshimura, Naruo, Kuwae, Yuko, Hirata, Kazuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635308/
https://www.ncbi.nlm.nih.gov/pubmed/28794368
http://dx.doi.org/10.2169/internalmedicine.8467-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635308/
https://www.ncbi.nlm.nih.gov/pubmed/28794368
http://dx.doi.org/10.2169/internalmedicine.8467-16

Ejemplares similares